Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-citrulline and Metformin in Duchenne's Muscular Dystrophy
NCT01995032Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Metformin + L-citrulline with Placebo (2 arms). Primary endpoint: Motor Function Measure D1 subscore at 26 weeks. Started Oct 2013; status: completed.
02
Drugs
metformincitrulline
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01995032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01995032.